Vaxart
在场
Vaxart 是一家在股票代码 VXRT (US) 下上市的公司。
高管
查看带有其 13 名主要高管的组织结构图
Vaxart 搜索最多的简介
- Steven Lo, President, Chief Executive Officer and Director
- Bob Yedid, Director
- Michael Finney, Chairman of the Board
高管在Vaxart变化
- Steven Lo已作为President, Chief Executive Officer and Director加入公司 (新闻发布的2024三月7号).
- Andrei Floroiu, Chief Executive Officer and Director, 已经离开公司 (新闻发布的2024一月17号).
- Michael Finney 曾任 Chairman of the Board, 现升职为 Chairman of the Board and Interim Chief Executive Officer (新闻发布的2024一月17号).
创建提醒
跟踪 Vaxart 的高管变动
生物技术
Vaxart 拥有 2,275 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Bruker has announced the acquisition of NanoString Technologies (公布2024四月18号).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (公布2024四月16号).
- Nurix Therapeutics 刚刚宣布为 175 筹款数百万美元。 (公布2024四月13号).
生物技术 行业的其他推荐联系人
消息
Vaxart 的最新新闻稿
- Vaxart to Host Investor Q&A Webcast | Vaxart, Inc.
- Vaxart Announces Adjournment of Annual Meeting of Stockholders | Vaxart, Inc.
- New Preclinical Data Demonstrate Two of Vaxart’s COVID-19 Vaccine Candidates Protect Against Omicron | Vaxart, Inc.
- Vaxart to Participate at the Jefferies Global Healthcare Conference | Vaxart, Inc.
- Vaxart Reports Positive Preliminary Data from the Phase 1b Trial of its Oral Norovirus Vaccine Candidates in Elderly Adults | Vaxart, Inc.
- Vaxart Announces the Publication of Studies in the Peer-Reviewed Journal Science Translational Medicine That Suggest Mucosal Immunization Could Decrease SARS-CoV-2 Transmission | Vaxart, Inc.
- Vaxart Provides Business Update and Reports First Quarter 2022 Financial Results | Vaxart, Inc.
- Vaxart to Present at World Vaccine Congress Washington 2022 on April 20 | Vaxart, Inc.
- Vaxart Appoints Edward Berg as Senior Vice President and General Counsel | Vaxart, Inc.
- Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results | Vaxart, Inc.
- View more press releases Close
通过电子邮件
